Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
Sign in with Google. Opens in new tab
bullish
Shanghai MicroPort MedBot Group
Watchlist
MicroPort MedBot IPO Trading - Decent Demand But Upside Is Limited from the Top-End
Equity Capital Markets
309 Views
01 Nov 2021 03:22
Shanghai MicroPort MedBot Group (MM), a surgical robot company, raised around US$200m in its Hong Kong IPO. In this note we will talk about the trading dynamics.
SUMMARY
(Sign Up to Access)
Full Insight
(Paid Plans Only, 3-minute read)
Related Insights
More »
Loading
Trending Collections
More »
Asia ECM
South Korea
Equity Bottom-Up
Index Rebalance
Event-Driven
Japan
Sell / Short Ideas
Singapore REITs
Asia Event-Driven
Unpaywalled Insights
Trending Insights
More »
HSCI Index Rebalance Preview and Stock Connect (Sep 2025): Plenty of Recent IPOs Could Be Added
BoE Surveys Sustain Resilience
NTT DC REIT IPO - Thoughts on Valuation
[Japan M&A] YAGEO Extends Shibaura TOB Limbo at FSA/METI/BOJ Request on FEFTA
KCC Corp: EB Issue of $625 Million To HD KSOE + KCC Corp and KCC Glass Share Swaps
Top Unpaywalled Insights
More »
Oversupply Meets Tepid Demand Weighing Down on Soybean Meal
[IO Technicals 2025/26] Bearish Momentum Intensifies
"The Data Bottleneck in Quant Finance — and How to Break It" With David Forino, CTO of Quanted
The New OS for Quant Finance: OpenBB, AI Agents & the Death of Legacy Terminals | New Barbarians ...
Curator's Cut: Building Materials Moves, Benchmarking Gold Miners & Semaglutide in India and Japan
Discussions
(Paid Plans Only)
Price Chart
(Sign Up to Access)
Insight Stream
MicroPort MedBot Pre-IPO - Valuation Appears Reasonable but Sentiment Will Weigh
21 Oct 2021
MicroPort MedBot Pre-IPO - Thoughts on Valuation
04 Oct 2021
Autonomous Driving- The Tesla Delusion
05 Apr 2018
Top
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.53.7
x